Approval of breast cancer treatment triggers $5M payment to Immunogen

Home › Approval of breast cancer treatment triggers $5M payment to Immunogen

Immunogen Inc., led by CEO Daniel Junius, has received a $5M milestone payment for its role in Kadcyla receiving approval in Japan.

02.06	Eastern North Pacific Tropical Weather Outlook
02.06	Atlantic Tropical Weather Outlook
02.06	Weekly Recap: Dyper Names CEO, Soft N Dry Diapers Expand Distribution to Brazil & More
02.06	Atlantic Tropical Weather Outlook
02.06	Eastern North Pacific Tropical Weather Outlook
02.06	Shops rush for Christmas stock as shipping costs surge
02.06	Successful entrepreneurs dont worry about being different
02.06	Eastern North Pacific Tropical Weather Outlook
More »

je.st